Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126153854 | 12615385 | 4 | F | 201505 | 20160829 | 20160802 | 20160902 | EXP | IT-PFIZER INC-2016368738 | PFIZER | FOIS, C.. PARADOXICAL EFFECT OF LEVETIRACETAM IN NEWLY DIAGNOSED TYPE II FOCAL CORTICAL DYSPLASIA. CLINICAL NEUROPHARMACOLOGY. 2016;10.1097/WNF.0000000000000171 | 18.00 | YR | M | Y | 0.00000 | 20160902 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126153854 | 12615385 | 1 | PS | LEVETIRACETAM. | LEVETIRACETAM | 1 | 250 MG, 2X/DAY | Y | 202869 | 250 | MG | BID | |||||||
| 126153854 | 12615385 | 2 | SS | LEVETIRACETAM. | LEVETIRACETAM | 1 | 500 MG, 2X/DAY | Y | 202869 | 500 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126153854 | 12615385 | 1 | Epilepsy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126153854 | 12615385 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126153854 | 12615385 | Condition aggravated | |
| 126153854 | 12615385 | Paradoxical drug reaction | |
| 126153854 | 12615385 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |